Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.
Lobo S, Dias A, Pedro AM, Ferreira M, Pinto-Oliveira A, São José C, Herrera-Mullar J, Pinto N, Colas C, Hüneburg R, Nattermann J, Boussemart L, van Hest LP, Moreira L, Horton C, Farengo Clark D, Tinschert S, Golmard L, Spier I, López-Fernández A, Oliveira D, Svrcek M, Bourgoin P, Coulet F, Delhomelle H, Davis J, Zäncker B, Lazaro C, Guerra J, Almeida ML, Carrera S, Patiño A, Gundlach P, Laszkowska M, Strong VE, Teixeira MR, Schrader I, Steinke-Lange V, Gullo I, Sousa S, Batista M, Aretz S, Balmaña J, Aronson M, Antoniazzi AP, Palmero EI, Mansfield P, van der Kolk LE, Cats A, van Dieren JM, Castellví-Bel S, Katona B, Karam R, Pereira PS, Benusiglio PR, Oliveira C.
Lobo S, et al. Among authors: van hest lp.
Gut. 2025 Nov 26:gutjnl-2024-334601. doi: 10.1136/gutjnl-2024-334601. Online ahead of print.
Gut. 2025.
PMID: 40998418
Free article.